Title:
COMPOSITE FORMULATION FOR TREATING ARTHRITIS
Document Type and Number:
WIPO Patent Application WO/2014/133329
Kind Code:
A1
Abstract:
The present invention provides a pharmaceutical formulation comprising: (a) a composite composition of C
lematis mandshurica
,
Trichosanthes kirilowii and Prunella vulgaris extracts; and (b) aceclofenac or a pharmaceutically acceptable salt thereof. The pharmaceutical formulation according to the present invention has excellent stability of the active ingredients, excellent pharmaceutical properties, etc., and can be easily produced so as to have a preferable elution pattern.
More Like This:
Inventors:
KIM GWAN-YOUNG (KR)
KIM WOONG SIK (KR)
RHEE HAE-IN (KR)
SHIN HO CHUL (KR)
KIM YONG-HYUK (KR)
KIM HUN-TAEK (KR)
KIM WOONG SIK (KR)
RHEE HAE-IN (KR)
SHIN HO CHUL (KR)
KIM YONG-HYUK (KR)
KIM HUN-TAEK (KR)
Application Number:
PCT/KR2014/001604
Publication Date:
September 04, 2014
Filing Date:
February 27, 2014
Export Citation:
Assignee:
SK CHEMICALS CO LTD (KR)
International Classes:
A61K9/54; A61K9/48; A61K36/428; A61K36/71
Foreign References:
| KR0180567B1 | 1999-03-20 | |||
| KR20050005894A | 2005-01-15 |
Other References:
MANKALA, S. K. ET AL.: "Development and evaluation of aceclofenac-loaded mucoadhesive microcapsules''.", JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH, vol. 2, no. 4, 2011, pages 245 - 254
SONG, Y. W. ET AL.: "Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial", CLINICAL THERAPEUTICS, vol. 29, no. 5, 2007, pages 862 - 873, XP022194348, DOI: doi:10.1016/j.clinthera.2007.05.006
GOWDA, D. V. ET AL.: "Development and evaluation of oral controlled release from aceclofenac sodium pellets", PHARMA SCIENCE MONITOR, vol. 2, no. 2, 2011, pages 82 - 104
SONG, Y. W. ET AL.: "Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial", CLINICAL THERAPEUTICS, vol. 29, no. 5, 2007, pages 862 - 873, XP022194348, DOI: doi:10.1016/j.clinthera.2007.05.006
GOWDA, D. V. ET AL.: "Development and evaluation of oral controlled release from aceclofenac sodium pellets", PHARMA SCIENCE MONITOR, vol. 2, no. 2, 2011, pages 82 - 104
Attorney, Agent or Firm:
PHIL & ONZI INT'L PATENT & LAW FIRM (KR)
특허법인 필앤온지 (KR)
특허법인 필앤온지 (KR)
Download PDF: